Arkadiusz Leniak

Mr. Arkadiusz Leniak

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2018 in Chemistry – An Asian Journal
Verified
Journal Article
Closed access
PDF file
MWMarek K. Węcławski
Marek K. Węcławski
IDIrena Deperasińska
Irena Deperasińska
MBMarzena Banasiewicz
Marzena Banasiewicz
DYDavid C. Young
David C. Young
ALArkadiusz Leniak
Arkadiusz Leniak
DGDaniel Gryko
Daniel Gryko

27 July 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MSMariola Stypik
Mariola Stypik
SMStanisław Michałek
Stanisław Michałek
NONina Orłowska
Nina Orłowska
MZMarcin Zagozda
Marcin Zagozda
MDMaciej Dziachan
Maciej Dziachan
MWMaciej Wieczorek
Maciej Wieczorek
Phosphoinositide 3-kinase (PI3K) is the family of lipid kinases participating in vital cellular processes such as cell proliferation, growth, migration, or cytokines production. Due to the high expression of these proteins in many human cells and their involvement in metabolism regulation, normal embryogenesis, or maintaining glucose homeostasis, the inhibition of PI3K (especially the first class which contains four subunits: α, β, γ, δ) is considered to be a promising therapeutic strategy for the treatment of inflammatory and autoimmune diseases such as systemic lupus erythematosus (SLE) or multiple sclerosis. In this work, we synthesized a library of benzimidazole derivatives of pyrazolo[1,5-a]pyrimidine representing a collection of new, potent, active, and selective inhibitors of PI3Kδ, displaying IC50 values ranging from 1.892 to 0.018 μM. Among all compounds obtained, CPL302415 (6) showed the highest activity (IC50 value of 18 nM for PI3Kδ), good selectivity (for PI3Kδ relative to other PI3K isoforms: PI3Kα/δ = 79; PI3Kβ/δ = 1415; PI3Kγ/δ = 939), and promising physicochemical properties. As a lead compound synthesized on a relatively large scale, this structure is considered a potential future candidate for clinical trials in SLE treatment.

30 July 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MSMariola Stypik
Mariola Stypik
MZMarcin Zagozda
Marcin Zagozda
SMStanisław Michałek
Stanisław Michałek
BDBarbara Dymek
Barbara Dymek
DZDaria Zdżalik-Bielecka
Daria Zdżalik-Bielecka
MWMaciej Wieczorek
Maciej Wieczorek
Phosphoinositide 3-kinase δ (PI3Kδ), a member of the class I PI3K family, is an essential signaling biomolecule that regulates the differentiation, proliferation, migration, and survival of immune cells. The overactivity of this protein causes cellular dysfunctions in many human disorders, for example, inflammatory and autoimmune diseases, including asthma or chronic obstructive pulmonary disease (COPD). In this work, we designed and synthesized a new library of small-molecule inhibitors based on indol-4-yl-pyrazolo[1,5-a]pyrimidine with IC50 values in the low nanomolar range and high selectivity against the PI3Kδ isoform. CPL302253 (54), the most potent compound of all the structures obtained, with IC50 = 2.8 nM, is a potential future candidate for clinical development as an inhaled drug to prevent asthma.

17 September 2025 in Journal of Chemical Information and Modeling
Verified
Journal Article
Open access
ALArkadiusz Leniak
Arkadiusz Leniak
WPWojciech Pietruś
Wojciech Pietruś
RKRafał Kurczab
Rafał Kurczab
The ability to predict log D directly from spectral patterns marks a conceptual shift in cheminformatics. In this work, we demonstrate that 1H and 13C NMR spectra, computationally generated from molecular structures and transformed into machine learning-compatible vectors, can approach and rival classical structure-based descriptors such as ECFP4 fingerprints in modeling the log D parameter. Through comprehensive benchmarking of nearly 70 models across seven algorithmic classes and three pH conditions, we show that concatenation of 1H and 13C NMR spectra offers the best trade-off between accuracy and efficiency. In the best case, a fused spectral CNN model achieved a root-mean-square error (RMSE) of 0.57 and a Q2 of 0.76 using a 400-dimensional input vector─closely matching the ECFP4 benchmark (RMSE 0.56, Q2 0.78) despite being five times smaller. These findings challenge the assumption that descriptor richness must come at the cost of dimensional complexity. SHAP-based analysis revealed modality-specific patterns: 13C regions linked to aromatic and carbonyl carbons (110-170 ppm) increased predicted log D, while 1H signals associated with polar groups, including OH, NH, amides, and ethers (2-4.5 and ∼8 ppm), reduced it. This positions NMR-based vectors as both interpretable and scalable alternatives to conventional fingerprints. By releasing a standalone graphical prediction tool based on our models, we make this paradigm practically accessible for real-world applications. This study establishes in silico-generated NMR spectra as valid and powerful descriptors in predictive modeling, paving the way for spectrum-driven approaches to drug discovery and property prediction.

1 March 2015 in Journal of Molecular Structure
Verified
Journal Article
Closed access
ALArkadiusz Leniak
Arkadiusz Leniak
JJJarosław Jaźwiński
Jarosław Jaźwiński

17 April 2023 in Molecules
Verified
Journal Article
Open access
PDF file
WPWojciech Pietruś
Wojciech Pietruś
MSMariola Stypik
Mariola Stypik
MZMarcin Zagozda
Marcin Zagozda
MBMartyna Banach
Martyna Banach
LGLidia Gurba-Bryśkiewicz
Lidia Gurba-Bryśkiewicz
MWMaciej Wieczorek
Maciej Wieczorek
As a member of the class I PI3K family, phosphoinositide 3-kinase δ (PI3Kδ) is an important signaling biomolecule that controls immune cell differentiation, proliferation, migration, and survival. It also represents a potential and promising therapeutic approach for the management of numerous inflammatory and autoimmune diseases. We designed and assessed the biological activity of new fluorinated analogues of CPL302415, taking into account the therapeutic potential of our selective PI3K inhibitor and fluorine introduction as one of the most frequently used modifications of a lead compound to further improve its biological activity. In this paper, we compare and evaluate the accuracy of our previously described and validated in silico workflow with that of the standard (rigid) molecular docking approach. The findings demonstrated that a properly fitted catalytic (binding) pocket for our chemical cores at the induced-fit docking (IFD) and molecular dynamics (MD) stages, along with QM-derived atomic charges, can be used for activity prediction to better distinguish between active and inactive molecules. Moreover, the standard approach seems to be insufficient to score the halogenated derivatives due to the fixed atomic charges, which do not consider the response and indictive effects caused by fluorine. The proposed computational workflow provides a computational tool for the rational design of novel halogenated drugs.